Childhood Immunization Schedules in the U.S. - 2011 Update

Tweet

Some highlights:

13-valent pneumococcal conjugate vaccine (PCV13)

- A PCV series begun with 7-valent PCV (PCV7) should be completed with PCV13.

- A single supplemental dose of PCV13 is recommended for all children 14 through 59 months of age who have received an age-appropriate series of PCV7. A single supplemental dose of PCV13 is recommended for all children 60 through 71 months of age with underlying medical conditions who have received an age-appropriate series of PCV7.

- The supplemental dose of PCV13 should be administered at least 8 weeks after the previous dose of PCV7.

- A single dose of PCV13 may be administered to children 6 through 18 years of age who have functional or anatomic asplenia, HIV infection or other immunocompromising conditions, cochlear implant, or cerebrospinal fluid leak.

- The pneumococcal polysaccharide vaccine (PPSV) should be administered to children 2 years of age or older with certain underling medical conditions at least 8 weeks after the last dose of PCV.

Influenza vaccine

- Administer 2 doses (separated by at least 4 weeks) to children 6 months through 8 years of age who are receiving influenza vaccine for the first time or who were vaccinated for the first time during the previous influenza season but only received 1 dose.

- Children 6 months through 8 years of age who received no doses of monovalent 2009 H1N1 vaccine or in whom the dosing schedule is unknown should receive 2 doses of 2010–2011 seasonal influenza vaccine.

Quadrivalent meningococcal conjugate vaccine (MCV4)

- Adolescents should be routinely immunized, preferably at 11 through 12 years, with a booster dose at 16 years of age.

Human papillomavirus vaccine (HPV)

- The quadrivalent vaccine (HPV4) and the bivalent vaccine (HPV2) are recommended for prevention of cervical precancers and cancers in females. HPV4 also is recommended for prevention of genital warts in females. HPV4 may be administered in a 3-dose series to males 9 through 18 years of age to reduce their likelihood of acquiring genital warts.

References:
Policy Statement: Recommended Childhood and Adolescent Immunization Schedules—United States, 2011. PEDIATRICS Vol. 127 No. 2 February 2011, pp. 387-388 (doi:10.1542/peds.2010-3203)